US · USD
BSX
Boston Scientific Corp
- Day's range
- US$42.95 – US$43.96
- Day's volume
- US$762.8m
- 52-week range
- US$42.63 – US$104.98
Follow BSX on Fuolio
See how BSX weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountBSX in numbers
- Market cap
- US$62.7bn
- P/B
- 2.51
- Dividend yield (12m)
- 0.00%
BSX price history
BSX risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -55.29% | -17.33% | +0.60% |
| Volatility (annualised) | 31.69% | 27.12% | 24.50% |
| Largest drawdown | -57.98% | -60.26% | -60.26% |
| Positive months | 4/12 | 22/36 | 35/60 |
How much did investing in BSX return?
US$1,000.00 invested on 01/09/2021 would be worth US$1,005.99 today.
- Value today in BSX
- US$1,005.99
- Return over the period
- +0.60%
- Return per year
- +0.12%
- In the S&P 500
- US$1,776.31
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
BSX fundamentals
Valuation
- P/E—
- P/B2.51
- EV/EBITDA11.26
- EV/EBIT15.09
- EV/Revenue2.98
- P/EBIT15.09
- P/S2.98
- P/OCF13.83
- P/FCF17.28
- Earnings yield6.63%
- PEG ratio—
- Earnings per share—
- Book value per shareUS$17.20
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio1.24
- Quick ratio0.74
- Cash ratio0.08
Efficiency
- Gross margin69.93%
- EBITDA margin26.51%
- Operating margin19.78%
- Net margin—
- Asset turnover0.46
Profitability
- ROE—
- ROA—
- ROIC15.83%
- Payout—
Growth
- Revenue CAGR (5 years)13.40%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
BSX indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/B | 5.84 | 6.05 | 4.40 | 3.78 | 3.65 | — | — | — |
| EV/EBITDA | 28.41 | 34.04 | 23.97 | 23.84 | 26.44 | 48.85 | 24.96 | 20.41 |
| Book value per share | US$16.33 | US$14.75 | US$13.14 | US$12.25 | US$11.65 | — | — | — |
| ROIC | 12.74% | 9.67% | 9.75% | 5.74% | 6.97% | — | — | — |
| Gross margin | 69.01% | 68.61% | 69.49% | 68.81% | 68.78% | 65.05% | 70.98% | 71.37% |
| EBITDA margin | 24.81% | 23.12% | 24.85% | 21.96% | 19.28% | 10.52% | 23.56% | 24.43% |
BSX financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | US$20.1bn | US$16.7bn | US$14.2bn | US$12.7bn | US$11.9bn | US$9.9bn |
| Cost of sales | -US$6.2bn | -US$5.3bn | -US$4.3bn | -US$4bn | -US$3.7bn | -US$3.5bn |
| Gross profit | US$13.9bn | US$11.5bn | US$9.9bn | US$8.7bn | US$8.2bn | US$6.4bn |
| EBITDA | US$5bn | US$3.9bn | US$3.5bn | US$2.8bn | US$2.3bn | US$1bn |
| EBIT | US$3.6bn | US$2.6bn | US$2.3bn | US$1.6bn | US$1.2bn | -US$80m |
| Net finance result | — | — | -US$358m | -US$508m | -US$123m | US$1m |
| Profit before tax | US$3.4bn | US$2.3bn | US$2bn | US$1.1bn | US$1.1bn | -US$79m |
| Income tax | -US$493m | -US$436m | -US$393m | -US$443m | -US$36m | -US$2m |
| Net income | — | — | — | — | — | — |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does BSX pay dividends?
BSX has no distributions on record.
About Boston Scientific
- Sector
- Manufacturing
Questions about BSX
How much is BSX today?
BSX is at US$43.23 (-0.96% on the day), last traded on 01/10/2026.
How much did BSX return in 12 months?
BSX returned -55.29% in 12 months, with annualised volatility of 31.69% and a largest drawdown of -57.98%.